The Global T cell Expert Consortium is a community of experts in T cell and vaccine research, epidemiology and global public health that aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic.
The Consortium was founded and is supported by Oxford Immunotec Ltd.
Professor Danny Altmann
UK
Professor Antonio Bertoletti
Singapore
Professor Rosemary Boyton
UK
Dr Marcus Buggert
Sweden
Professor Shane Crotty
USA
Professor Tao Dong
UK
Professor Helen Fletcher
UK
Professor Paul Moss
UK
Professor Peter Openshaw
UK
Professor Alessandro Sette
USA
More consortium members to be confirmed soon!
Meet Professor Alessandro Sette and Professor Daniela Weiskopf
How to examine the long-term efficacy of vaccines
Preparing for an unknown pathogen outbreak
Research during the
COVID-19 pandemic
Immunological implications of vaccine administration scheduling
SARS-CoV-2 variants and implications for vaccine efficacy
What is the role of T cells in the response to SARS-CoV-2?
The role of T cells in vaccine development
Assessment of SARS-CoV-2 infection status and T cell responses
The Global T cell Expert Consortium is an initiative designed to bring together leading experts worldwide in T cell research.
The current COVID-19 pandemic has exacerbated the challenges we face in managing and protecting against infectious diseases. More than ever, we require an understanding of the immune response, the role of T cells in cell-mediated immunity against infectious diseases such as SARS-CoV-2, and how we can harness T cell responses in the fight against COVID-19.
The consortium aims to advance the frontiers of T cell research and education by providing a platform for global experts to come together, share their expertise and insights, and collaborate to address the unmet needs and remaining challenges in T cell testing and research. The consortium will educate on T cells by generating a series of publicly available resources such as webinars and podcasts. The agenda of this initiative and its associated educational content are owned and driven by our consortium experts, with support from Oxford Immunotec.
If you have any questions or suggestions for our experts, please submit them using the form on this page.
Click here to visit the Oxford Immunotec website.